New York, USA – October 24, 2023 – On October, 2nd, two brilliant scientists, Katalin Karikó and Drew Weissman, were honored with the 2023 Nobel Prize in Physiology for their discoveries-how to deliver mRNA into cells inside the body by enveloping the molecules inside lipid bubbles-significantly advancing the development of effective liposome-based mRNA vaccines combating COVID-19. mRNA technology was essential for developing some COVID-19 vaccines, playing a pivotal role in the ongoing battle against the pandemic. Creative Biolabs, a USA-based biotechnology company at the forefront of biomedical research support, is thrilled to provide a wide range of liposome development services to meet the global demands regarding mRNA vaccine research.
“They made groundbreaking discoveries in mRNA technology and mRNA delivery using lipid nanoparticles, which expedited the development of mRNA vaccines in record time,” says a scientist at Creative Biolabs. “Indeed, studies have demonstrated that liposome-based immune activation can offer effective systems for inducing immunity in vaccine development research.”
With extensive experience in liposome development for applications in immune activation, brain drug delivery, and gene editing, Creative Biolabs offers one-stop liposome development services for immune activation and mRNA vaccine development based on cutting-edge drug delivery platforms and pre-clinical vaccine platforms.
In addition, Creative Biolabs offers liposome encapsulated nucleic acid development services and assures reliable support for global researchers through thoughtful design and comprehensive evaluation in the development process of any liposome formulation.
Over the past several years, this company has offered liposome encapsulation services for nucleic acids to hundreds of research projects based on its advanced encapsulation technologies, receiving high praise from customers around the world.
“Our scientists maintain their expertise to provide customers with a comprehensive portfolio of services that have proven to meet the critical processes, quality standard, and regulatory demands, expediting clients’ mRNA vaccine development programs,” stated the director scientist of Creative Biolabs.
Learn more information about liposome development services at Creative Biolabs, please visit https://www.creative-biolabs.com/lipid-based-delivery.
About Creative Biolabs
Creative Biolabs, leading in liposome drug delivery, is dedicated to delivering comprehensive and custom liposome development covering the entire new formulation development pipeline to support biomedical research worldwide.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://www.creative-biolabs.com/lipid-based-delivery
